Intelligence digest
This Week in GLP-1s
Weekly coverage of FDA actions, clinical trials, pharma news, and patient community signal — curated and reviewed by our editorial team.
Sources
6
Cadence
Weekly
Free
Always
5 editions published
W18
April 26 – May 2, 2026
GLP-1 medications drive fat loss while largely preserving muscle, review finds
PolicyResearchPatients10 stories
W17
April 19-25, 2026
FDA updates liraglutide label, removing pregnancy contraindication and suicide warning
ResearchPatients4 stories
W16
April 12-18, 2026
US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises | US healthcare | The Guardian
PolicyResearchIndustryPatients7 stories
W15
April 5-11, 2026
AI scans 400,000 Reddit posts to surface overlooked GLP-1 side effects
PolicyResearchIndustry5 stories
W14
March 29 – April 4, 2026
FDA approves Foundayo, Eli Lilly's new oral GLP-1 pill for obesity
PolicyIndustry3 stories